For instance, excess CAF-secreted EGF can competitively bind to EGFR with cetuximab and activate MAPK to promote cetuximab resistance in colorectal cancer.253 Similarly, expressed PDGF-C in CAFs promotes angiogenesis and inhibits the effect of VEGF inhibitor.366. Here, EGFR is linked to colorectal cancer.